U.S. Markets closed

Vanda Pharmaceuticals Announces Participation at the Jefferies 2019 Global Healthcare Conference

WASHINGTON, May 31, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (VNDA) announced today that Mihael H. Polymeropoulos, co-founder and Chief Executive Officer, will present at the Jefferies 2019 Global Healthcare Conference in New York City on Tuesday, June 4, 2019. A corporate presentation is scheduled for 11:00 a.m. Eastern Time.

The corporate presentation given at the Jefferies 2019 Global Healthcare Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days. To access the presentation, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentation.

About Vanda Pharmaceuticals Inc.

Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.

Company Contact:
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428


View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-the-jefferies-2019-global-healthcare-conference-300859795.html